BMC Urology

Section Editors

Steven Brandes, Washington University
Cosimo De Nunzio, Ospedale Sant'Andrea
John Gearhart, Johns Hopkins Children's Center
Debra E Irwin, University of North Carolina at Chapel Hill
Jose Karam, MD Anderson Cancer Center
Ercan Kocakoc, Bezmialem Vakif University
Salvatore Micali, University of Modena and Reggio Emilia
Charles J Rosser, University of Florida
Mostafa Taymour, University of Cairo

Executive Editor

Hayley Henderson, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

MRSA in the urology ward

Stepwise infection control strategy that includes a reduction or avoidance of antimicrobial prophylaxis in minimally invasive surgery over ten years could contribute to a reduction in hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and clinically significant infections.

BMC Urology 2013, 13:35
Daptomycin and vancomycin-resistant UTIs

Daptomycin appears to be an effective therapeutic option in the management of vancomycin-resistant enterococcal urinary tract infections (UTI), providing further evidence that this antibiotic based treatment could be a valuable treatment option for these problematic UTIs.

BMC Urology 2013, 13:33
Laser-supported LPN for renal tumours

Laparoscopic laser-supported partial nephrectomy without clamping of the renal vessels offers several advantages over the conventional open partial nephrectomy and appears to be a safe approach to the resection of peripheral and small renal tumours with few complications.

BMC Urology 2013, 13:31
RBM3, a new biomarker in bladder cancer

Reduced RNA-binding motif protein 3 (RBM3) expression is associated with more aggressive tumours and reduced survival rates in patients with urothelial bladder cancer, and could be used as a prognostic biomarker for treatment stratification in patients with this disease.

BMC Urology 2013, 13:17
View more articles

RSS

Comments

mistake in figure 1

Comment on: Arlandis-Guzman et al. BMC Urology 2011, 11:9
Contraindications

Comment on: Weiss et al. BMC Urology 2010, 10:2
Related commentary published in BMC Urology

Comment on: Nakamura et al. BMC Urology 2009, 9:12

Hot topic

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

Khullar V, Cambronero J, Angulo JC, Wooning M, Blauwet MB, Dorrepaal C and Martin NE

BMC Urology 2013, 13:45

Scope

BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Urology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcurol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

RSS

BMC series blog

25 September 2013: BMC and the Royal College of General Practitioners

19 September 2013: Enhancing sexual health services through E-health technology

19 September 2013: Promoting respiratory health in Europe: a lot achieved, still more to do – ERS 2013

Section Editor Profile

Cosimo De Nunzio, MD, PhD, is Consultant Urologist and contract Professor at the Department of Urology, Ospedale Sant'Andrea, University "La Sapienza", Roma, Italy. His research focus is prostatic disorders with a particular interest in voiding dysfunction, Benign prostatic Hyperplasia and prostate cancer diagnosis and management.

"I am pleased to be involved with BMC Urology first as a reviewer and now as Section Editor for Voiding Dysfunction. BMC Urology is an open access journal publishing original peer-reviewed articles, currently 10th on the SCImago Journal & Country Rank table and with and increasing number of manuscripts published in the last 4 years. When I joined BMC Urology, I have been particularly impressed by the excellent group of Section and Associate Editors involved in the Editorial Board and notwithstanding their young age, they are extremely expert in their field of interest. The journal's excellent editorial staff and the rapidity of the peer review process is another crucial quality of this journal. Moreover, I strongly support the open access platform used by BMC Urology which makes the specialized knowledge of urology more widely available to the scientific community at large, independently of the institutional affiliation or economic resources."

RSS